Ricci 1987.
| Study characteristics | ||
| Methods |
Allocation: "randomisation list" Design: parallel‐group |
|
| Participants |
Number: 10 analysed Age: mean 36 Gender: 6 M, 4 F Setting: outpatients, Italy Eligibility criteria: Ménière's syndrome, investigator‐definedExclusion criteria: allergy to betahistine, ulcer, other medical conditions as defined Baseline characteristics: similar baseline characteristics |
|
| Interventions | Betahistine 8 mg 3 times a day versus placebo for variable duration (10 x mean duration of interval between attacks for each patient) Intervention group: n = 5 Comparator group: n = 5 Use of additional interventions: none |
|
| Outcomes | Primary outcome: narrative only (description of each patient's history)Secondary outcomes: none | |
| Funding sources | Not stated | |
| Declarations of interest | Not stated | |
| Notes | Participants lost to follow‐up: not stated | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | "Randomisation list" |
| Allocation concealment (selection bias) | Unclear risk | Method not stated |
| Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Double‐blind, but no further information |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Double‐blind, but no further information |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | No information |
| Selective reporting (reporting bias) | High risk | Limited outcome data and no information on adverse events |
| Other bias | Unclear risk | — |